TELA Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
TELA Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2024.
  • TELA Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2024 was $76.8M, a 8.01% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $76.8M +$5.7M +8.01% Dec 31, 2024 10-K 2025-03-21
Q4 2023 $71.1M +$10.9M +18.2% Dec 31, 2023 10-K 2025-03-21
Q4 2022 $60.2M +$10.4M +20.8% Dec 31, 2022 10-K 2024-03-22
Q4 2021 $49.8M +$8.06M +19.3% Dec 31, 2021 10-K 2023-03-23
Q4 2020 $41.7M +$6.93M +19.9% Dec 31, 2020 10-K 2022-03-23
Q4 2019 $34.8M +$5.42M +18.5% Dec 31, 2019 10-K 2021-03-25
Q4 2018 $29.4M Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.